ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-2-METHYLPROPANOATE
Compound with spectra: 1 NMR
![ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-2-METHYLPROPANOATE](/api/compound/Bf1Es9CunpT.png?ph=true&h=300&w=458 "ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-2-METHYLPROPANOATE")
| SpectraBase Compound ID | Bf1Es9CunpT |
|---|---|
| InChI | InChI=1S/C19H28NO8P/c1-4-27-17(21)14(2)13-29(24,25)11-10-16(18(22)26-3)20-19(23)28-12-15-8-6-5-7-9-15/h5-9,14,16H,4,10-13H2,1-3H3,(H,20,23)(H,24,25)/t14?,16-/m0/s1 |
| InChIKey | CCMHIDORENIZMS-WMCAAGNKSA-N |
| Mol Weight | 429.41 g/mol |
| Molecular Formula | C19H28NO8P |
| Exact Mass | 429.155254 g/mol |
| Enantiomer InChIKey | CCMHIDORENIZMS-BZSJEYESSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
DIETHYL_(3-S)-2-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-ETHYLPHOSPHONATE
N-(N-CARBOXY-L-gamma-GLUTAMYL)-L-GLUTAMIC ACID, N,alpha,1-TRIBENZYL ESTER
L-(+)-N-(Benzyloxycarbonyl)-4-[3-(4-methoxyphenoxy)phenoxy[phenylalanine Methyl Ester
WZUPFUJAVKNMDS-UHFFFAOYSA-N
L-(-)-N-carboxytyrosine, N-benzyl p-nitrophenyl ester
N-carboxy-dl-norvaline, N-benzyl 2,4,6-trichlorophenyl ester
N5-Acetyl-N5-benzoyloxy-N2-benzyloxycarbonyl-L-ornithine tert-butyl ester
N-<(3S)-3-[(3S)-3-BENZYLOXYCARBONYLAMINO-3-TERT.-BUTYLOXYCARBONYLPROPYLAMINO]-3-TERT.-BUTYLOXYCARBONYLPROPYL>-SARCOSIN-ETHYLESTER
N-CARBOXY-L-LEUCINE, N-BENZYL 2,4,6-TRICHLOROPHENYL ESTER
(2S)-3-[benzoxy(nitroso)amino]-2-(benzyloxycarbonylamino)propionic acid benzyl ester
| Title | Journal or Book | Year |
|---|---|---|
| A Virtual Screening Hit Reveals New Possibilities for Developing Group III Metabotropic Glutamate Receptor Agonists | Journal of Medicinal Chemistry | 2010 |